Multiple Myeloma
  • About Us
  • Get Involved
  • Resources
    • Submissions
    • Participate in research
    • The Burden of Multiple Myeloma in New Zealand
    • Other myeloma related organisations
    • BoD Speech
    • Burden of Disease
    • Videos
  • News
    • Newsletters
    • Research
    • Research Review
    • Covid-19
  • Events
  • Fundraising
  • Contact Us
  • Donate now
Select Page

Multiple Myeloma Research Review

by Myeloma NZ | May 29, 2020 | Research Review

Highlights include:

  • Associations with OS in NZ MM patients
  • VTE risk with lenalidomide regimens for MM despite thromboprophylaxis
  • Retrospective study of with t(14;16) MM

Download here: Multiple Myeloma Research Review Issue 34

Recent Posts

  • Jessica from Past, Present and Fuchsia
  • Sir Sam Neil joins the growing call for access to standard blood cancer treatments
  • Rodger Tiedemann: The cancer treatments you need are available, just not in NZ
  • Father of two who’s spent his life serving the public told to consider Australia for funded cancer treatment
  • Bitter pill: New report finds NZ lags behind in timely access to medicines

Recent Comments

No comments to show.

About us
Get involved

News
Resources

Videos
Donate now

Copyright 2024 Myeloma New Zealand, All Right Reserved